| 8987242 |
Morpholinone compounds as factor IXA inhibitors |
Samuel Chackalamannil, Tin-Yau Chan, Mariappan V. Chelliah, Michael P. Dwyer, William J. Greenlee +6 more |
2015-03-24 |
| 8987195 |
HCV NS3 protease inhibitors |
Thomas Bara, Sathesh Bhat, Dipshikha Biswas, Linda Brockunier, Duane A. Burnett +17 more |
2015-03-24 |
| 8642582 |
Morpholinone compounds as factor IXa inhibitors |
Hidemitsu Nishida, Fumihiko Saitoh, Tomokazu Hirabayashi, Samuel Chackalamannil, Tin-Yau Chan +4 more |
2014-02-04 |
| 8609676 |
4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors |
Mariappan V. Chelliah, Samuel Chackalamannil, William J. Greenlee, Keith Eagan, Zhuyan Guo +6 more |
2013-12-17 |
| 8148363 |
Heterocyclic compounds as factor IXA inhibitors |
William J. Greenlee, Yan Xia, Tin-Yau Chan, Mariappan V. Chelliah, Samuel Chackalamannil +6 more |
2012-04-03 |
| 7897601 |
Cannabinoid receptor modulators |
Samuel Chackalamannil, Mariappan V. Chelliah, Keith Eagen, Jack D. Scott, Yuguang Wang +2 more |
2011-03-01 |
| 7741318 |
Pyrazolo [1,5-A]pyrimidine adenosine A2a receptor antagonists |
Samuel Chackalamannil, Bernard R. Neustadt, Xiaobang Gao |
2010-06-22 |
| 7713985 |
Adenosine Aa2 receptor antagonists |
Samuel Chackalamannil, Andrew Stamford |
2010-05-11 |
| 7713999 |
Thrombin receptor antagonists |
Samuel Chackalamannil, William J. Greenlee, Yuguang Wang, Yan Xia, Enrico Veltri +1 more |
2010-05-11 |
| 7442712 |
Constrained himbacine analogs as thrombin receptor antagonists |
Mariappan V. Chelliah, Samuel Chackalamannil, Yan Xia, William J. Greenlee, Yuguang Wang +5 more |
2008-10-28 |
| 7037920 |
Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists |
Samuel Chackalamannil, Mariappan V. Chelliah, Yan Xia |
2006-05-02 |
| 6326380 |
Thrombin receptor antagonists |
Samuel Chackalamannil, Theodros Asberom, Yan Xia, Dario Doller, Michael F. Czarniecki |
2001-12-04 |
| 6063847 |
Thrombin receptor antagonists |
Samuel Chackalamannil, Theodros Asberom, Yan Xia, Dario Doller, Michael F. Czarniecki |
2000-05-16 |
